134 related articles for article (PubMed ID: 10714456)
1. Effect of experimental fasciolosis on antipyrine metabolism and clearance in water buffaloes.
Jiang SX; Bayón JE; Ferre I; Mao XZ; González-Gallego J
Vet Parasitol; 2000 Mar; 88(3-4):177-86. PubMed ID: 10714456
[TBL] [Abstract][Full Text] [Related]
2. Plasma aspartate aminotransferase (AST), glutamate dehydrogenase (GLDH) and gamma-glutamyl transpeptidase (GGT) activities in water buffaloes with experimental subclinical fasciolosis.
Yang Q; Mao WH; Ferre I; Bayón JE; Mao XZ; González-Gallego J
Vet Parasitol; 1998 Jul; 78(2):129-36. PubMed ID: 9735917
[TBL] [Abstract][Full Text] [Related]
3. The effect of sex on antipyrine metabolism in cattle at different ages.
Janus K; Antoszek J
J Vet Pharmacol Ther; 1999 Jun; 22(3):163-9. PubMed ID: 10447826
[TBL] [Abstract][Full Text] [Related]
4. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
[TBL] [Abstract][Full Text] [Related]
5. Influence of short-term water deprivation on antipyrine disposition in calves.
Janus K; Muszczynski Z; Suszycka J
Res Vet Sci; 1997; 63(1):1-3. PubMed ID: 9368948
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites.
St Peter JV; Abul-Hajj Y; Awni WM
Pharm Res; 1991 Dec; 8(12):1470-6. PubMed ID: 1808608
[TBL] [Abstract][Full Text] [Related]
7. Effect of age on the pharmacokinetics of antipyrine in calves.
Janus K; Suszycka J
Res Vet Sci; 1996 May; 60(3):234-7. PubMed ID: 8735513
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a commercially available enzyme-linked immunosorbent assay for detecting antibodies to Fasciola hepatica and Fasciola gigantica in cattle, sheep and buffaloes in Australia.
Molloy JB; Anderson GR; Fletcher TI; Landmann J; Knight BC
Vet Parasitol; 2005 Jun; 130(3-4):207-12. PubMed ID: 15925723
[TBL] [Abstract][Full Text] [Related]
9. The effect of age and sex on metabolism and urinary excretion of antipyrine.
Jorquera F; Almar M; Pozuelo M; Sansegundo D; González-Sastre M; González-Gallego J
J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
[TBL] [Abstract][Full Text] [Related]
10. The effect of experimental fascioliasis on the pharmacokinetics of antipyrine and sulphadimidine in desert sheep.
Elsheikh HA; Ali BH
J Vet Pharmacol Ther; 1997 Jun; 20(3):167-72. PubMed ID: 9185081
[TBL] [Abstract][Full Text] [Related]
11. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
12. Antipyrine metabolite formation and excretion in patients with chronic renal failure.
Teunissen MW; Kampf D; Roots I; Vermeulen NP; Breimer DD
Eur J Clin Pharmacol; 1985; 28(5):589-95. PubMed ID: 4043202
[TBL] [Abstract][Full Text] [Related]
13. Immunodiagnosis of bovine fasciolosis using Fasciola hepatica excretory-secretory antigens ELISA.
el-Aziz MM; Ghazy AA; Effat MM
J Egypt Soc Parasitol; 2001 Apr; 31(1):327-34. PubMed ID: 12557952
[TBL] [Abstract][Full Text] [Related]
14. Experimental ovine fasciolosis: antipyrine clearance as indicator of liver damage.
Ferre I; López P; Rojo-Vázquez FA; González-Gallego J
Vet Parasitol; 1996 Mar; 62(1-2):93-100. PubMed ID: 8638398
[TBL] [Abstract][Full Text] [Related]
15. Effect of early treatment with rafoxanide on antipyrine clearance in sheep infected with Fasciola hepatica.
Benchaoui HA; McKellar QA
Xenobiotica; 1993 Apr; 23(4):439-48. PubMed ID: 8101676
[TBL] [Abstract][Full Text] [Related]
16. Assay of antipyrine and its main metabolites 3-hydroxymethylantipyrine, norantipyrine and 4-hydroxyantipyrine in urine.
Brendel E; Meineke I; de Mey C
J Pharm Biomed Anal; 1989; 7(12):1783-90. PubMed ID: 2490567
[TBL] [Abstract][Full Text] [Related]
17. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
[TBL] [Abstract][Full Text] [Related]
18. Blood eicosanoids and immune indices during fasciolosis in water buffaloes.
Chen L; Daugschies A; Wang B; Mao X
Parasitol Int; 2000 Dec; 49(4):273-8. PubMed ID: 11077261
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
Rivière JH; Back DJ; Breckenridge AM; Howells RE
Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of antipyrine in calves after intravenous and oral administration.
Janus K; Muszczynski Z; Suszycka J
J Vet Pharmacol Ther; 1996 Oct; 19(5):408-10. PubMed ID: 8905578
[No Abstract] [Full Text] [Related]
[Next] [New Search]
